World News | South Korea: Seegene Develops Diagnostic Reagent for Monkeypox

Get latest articles and stories on World at LatestLY. Seegene, a South Korean molecular diagnosis company, said on June 28 that it has developed the diagnostic reagent for monkeypox "NovaplexTM MPXV Assay."

Representative Image

Seoul [South Korea], June 29 (ANI/Global Economic): Seegene, a South Korean molecular diagnosis company, said on June 28 that it has developed the diagnostic reagent for monkeypox "NovaplexTM MPXV Assay."

Seegene explained that it has developed the diagnostic reagent that accurately detects the monkeypox based on its reagent development know-how accumulated for 20 years and its own artificial intelligence (AI)-based reagent development automation system, "SGDDS (Seegene Digitalized Development System)."

Also Read | US Federal Trade Commission Sues Walmart for Facilitating Money Transfer Scams Worth USD 197 Million.

Monkeypox, which is an endemic disease in Africa, has spread in some 50 countries already since it is first discovered in the UK last month, and a positive case was confirmed for the first time in Korea on the 22nd.

The World Health Organization (WHO) said that the monkeypox is clearly an evolving health threat and stressed that the government and institutions should start carefully monitoring, contact tracing, and diagnostic tests. The fatality rate of monkeypox reaches 3-6 per cent, and children and immunocompromised are in high-risk groups.

Also Read | Russian Missile Attack on Crowded Ukrainian Shopping Mall: India Says Civilian Deaths 'Deeply Disturbing'.

There is a treatment for monkeypox, so it can be treated after a diagnosis is accurately made. In particular, treatments are more effective in the early stages of infection. Thus experts said considering the characteristics of monkeypox, which has a maximum 21-day incubation, rapid test and diagnosis such as PCR tests are required to quickly prevent the pandemic.

Seegene said the new product can be detected the monkeypox virus in an hour and a half, and it has quickly developed to prevent the pandemic. Seegene will supply it to countries where the monkeypox virus is spreading, including Europe. (ANI/Global Economic)

(The above story is verified and authored by ANI staff, ANI is South Asia's leading multimedia news agency with over 100 bureaus in India, South Asia and across the globe. ANI brings the latest news on Politics and Current Affairs in India & around the World, Sports, Health, Fitness, Entertainment, & News. The views appearing in the above post do not reflect the opinions of LatestLY)

Share Now

Share Now